‌Lipohypertrophy is when lumps of fat or scar tissue form under your skin. It is caused by repeat injections or infusions in the same area of the body and is more common in people with diabetes.

A common side effect of treating your insulin-dependent diabetes is lipohypertrophy. This occurs because of multiple injections in the same area of skin over an extended period of time. Rotating your ...

This section presents medications that are known to potentially lead to 'Lipohypertrophy' as a side effect. It's important to note that mild side effects are quite common with medications. Please be ...

Lipohypertrophy can be unpleasant for you from an aesthetic perspective and it can also affect the rate at which insulin is absorbed so can also lead to erratic blood glucose results. Lipohypertrophy ...

Findings from 16-week trial of novel compression patch will be shared for the first time at the 85 th Scientific Sessions of the American Diabetes Association, beginning today "The findings from this ...

DENVER -- People with HIV who received semaglutide (Ozempic, Wegovy) had reduced levels of several inflammatory biomarkers associated with cardiovascular disease, a randomized controlled trial showed.

Two new studies provide evidence for the first time that insulin is not absorbed effectively when injected into Lipohypertrophy (LH). LH has long been associated with poor insulin absorption; in a ...

A 76-year-old man with long-standing type 2 diabetes presented with painless, rubbery, hyperpigmented masses on his abdomen. A diagnosis of insulin-mediated lipohypertrophy was made.

A 34-year-old HIV-infected man presented with multidermatomal herpes zoster in December 1996, and was treated with acyclovir. His baseline CD4+ cell count was 180 cells/mm 3. He started antiretroviral ...

People on weight loss medications are being warned not to follow the latest microdosing trend which has been gaining popularity in the run-up to the festive season. This involves taking smaller doses ...